Current status of liquid ventilation.

Perfluorochemical liquid has been used experimentally to enhance mechanical ventilation for the past 30 years. Liquid ventilation is one of the most extensively studied revolutionary medical therapies being considered for use in practice. Since 1989, when the first human neonates were treated with perfluorochemical liquid, more than 500 human patients--neonate, pediatric, and adult--have been treated with liquid ventilation as part of clinical trials. However, most of the clinically relevant information known to the medical field about liquid ventilation still comes from the laboratory. This paper seeks to briefly present current information available from studies involving liquid ventilation, both laboratory-based and clinical trials, as well as to inform the reader on patient management. In addition, we attempt to elucidate future directions.

[1]  J. Arnold,et al.  Optimizing Intrapulmonary Perfluorocarbon: Dosing Method and Mode of Ventilation 182 , 1998, Pediatric Research.

[2]  T. Shaffer,et al.  Perfluorochemical (PFC) Evaporation from the Lungs: Effect of Initial Dose † 1773 , 1998, Pediatric Research.

[3]  E. M. Haase,et al.  Perfluorocarbons Decrease Bacterial Adhesion to Epithelial Cells • 231 , 1998, Pediatric Research.

[4]  M. Wolfson,et al.  Intratrachael (IT) Delivery of a Nanocrystal Gentamicin / Perflurochemical(G/PFC) Suspension in Normal (N) and Injured (I) Lungs † 1431 , 1998, Pediatric Research.

[5]  T. Shaffer,et al.  Liquid-assisted ventilation: physiology and clinical application. , 1997, Annals of medicine.

[6]  J. Connett,et al.  Exogenous surfactant and partial liquid ventilation: physiologic and pathologic effects. , 1997, American journal of respiratory and critical care medicine.

[7]  M. Wolfson,et al.  Virtual bronchoscopy with perfluoronated hydrocarbon enhancement. , 1997, Academic radiology.

[8]  T. Shaffer,et al.  Comparison of perfluorochemical fluids used for liquid ventilation: Effect of endotracheal tube flow resistance , 1997, Pediatric pulmonology.

[9]  A. Spitzer,et al.  Interactions Between Perfluorochemicals and Lung Surfactant: Extraction of SP-B. † 804 , 1997, Pediatric Research.

[10]  K. Park,et al.  Improved surface active properties of perfluorocarbon and exogenous pulmonary surfactant mixtures. ♦ 1804 , 1997, Pediatric Research.

[11]  T. Shaffer,et al.  Influences on Perfluorochemical (PFC) Blood Uptake: In-Vitro Assessment. ♦ 322 , 1997, Pediatric Research.

[12]  A. Rotta,et al.  Partial Liquid Ventilation (PLV) Reduces Pulmonary Leukostasis in a Model of Acute Lung Injury (ALI). ♦ 212 , 1997, Pediatric Research.

[13]  S. Verbrugge,et al.  Combining partial liquid ventilation with nitric oxide to improve gas exchange in acute lung injury , 1997, Intensive Care Medicine.

[14]  S. Bratton,et al.  High-frequency oscillatory ventilation with partial liquid ventilation in a model of acute respiratory failure. , 1997, Critical care medicine.

[15]  Thomas H. Shaffer,et al.  Partial Liquid Ventilation with Perflubron in Premature Infants with Severe Respiratory Distress Syndrome , 1996 .

[16]  D. Steinhorn,et al.  Partial liquid ventilation enhances surfactant phospholipid production. , 1996, Critical care medicine.

[17]  M R Wolfson,et al.  Liquid assisted ventilation: An alternative ventilatory strategy for acute meconium aspiration injury , 1996, Pediatric pulmonology.

[18]  T. Shaffer,et al.  SELECTIVE PULMONARY VASODILATION AND PULMONARY DISTRIBUTION OF RADIOLABELED HISTAMINE DURING LIQUID VENTILATION (LV) IN HYPOXIC NEWBORN (NB) LAMBS† 2336 , 1996, Pediatric Research.

[19]  R. Hirschl,et al.  Partial liquid ventilation provides effective gas exchange in a large animal model. , 1996, Journal of critical care.

[20]  J. E. Fisher,et al.  Perfluorocarbon-associated gas exchange improves oxygenation, lung mechanics, and survival in a model of adult respiratory distress syndrome. , 1996, Critical care medicine.

[21]  P. Wollmer,et al.  Evaluation of lung function after intratracheal perfluorocarbon administration in healthy animals. , 1996, Critical care medicine.

[22]  T. Shaffer,et al.  Liquid ventilation in premature lambs: uptake, biodistribution and elimination of perfluorodecalin liquid. , 1996, Reproduction, fertility, and development.

[23]  R. Dechert,et al.  Liquid ventilation in adults, children, and full-term neonates , 1995, The Lancet.

[24]  P. Dandona,et al.  A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. , 1995, Critical care medicine.

[25]  M. Wolfson,et al.  Combined gas ventilation and perfluorochemical tracheal instillation as an alternative treatment for lethal congenital diaphragmatic hernia in lambs. , 1995, Journal of pediatric surgery.

[26]  G. W. Gross,et al.  Use of liquid ventilation with perflubron during extracorporeal membrane oxygenation: chest radiographic appearances. , 1995, Radiology.

[27]  M. Papo,et al.  Partial liquid ventilation in premature lambs with respiratory distress syndrome: efficacy and compatibility with exogenous surfactant. , 1995, The Journal of pediatrics.

[28]  R. Bartlett,et al.  Lung management with perfluorocarbon liquid ventilation improves pulmonary function and gas exchange during extracorporeal membrane oxygenation (ECMO). , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[29]  K. M. Sekins,et al.  Utility of a perfluorochemical liquid for pulmonary diagnostic imaging. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[30]  B. Fuhrman,et al.  Perfluorocarbon‐associated gas exchange (partial liquid ventilation) in respiratory distress syndrome A prospective, randomized, controlled study , 1993, Critical care medicine.

[31]  Thomas H Shaffer,et al.  Gaseous Exchange and Acid-Base Balance in Premature Lambs during Liquid Ventilation since Birth , 1976, Pediatric Research.

[32]  J. Modell,et al.  Distribution and retention of fluorocarbon in mice and dogs after injection or liquid ventilation. , 1973, Toxicology and applied pharmacology.